Spots Global Cancer Trial Database for immunologic technique
Every month we try and update this database with for immunologic technique cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation | NCT00052520 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... B-cell Adult Ac... B-cell Childhoo... Childhood Chron... Childhood Myelo... Chronic Myelomo... Essential Throm... Polycythemia Ve... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Acute... T-cell Adult Ac... T-cell Childhoo... | therapeutic all... aldesleukin peripheral bloo... allogeneic bone... laboratory biom... gene expression... immunologic tec... flow cytometry polymerase chai... cytogenetic ana... staining method | - | Fred Hutchinson Cancer Center | |
| Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | NCT00673569 | Lung Cancer | erlotinib hydro... gene expression... protein express... immunoenzyme te... immunologic tec... laboratory biom... needle biopsy | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 | NCT00896701 | Leukemia | flow cytometry immunologic tec... laboratory biom... | 15 Years - | Alliance for Clinical Trials in Oncology | |
| Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer | NCT00899132 | Non-melanomatou... Pancreatic Canc... Small Intestine... Testicular Germ... | in situ hybridi... protein express... immunologic tec... | - | Case Comprehensive Cancer Center | |
| Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 | NCT00896662 | Lymphoma Solid Tumor | immunologic tec... laboratory biom... pharmacological... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | NCT00453050 | Melanoma (Skin) Metastatic Canc... | imiquimod indocyanine gre... flow cytometry immunologic tec... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma | NCT00478075 | Multiple Myelom... | bortezomib immunologic tec... samarium Sm 153... | 18 Years - | Mayo Clinic | |
| Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT00742404 | Multiple Myelom... | bortezomib dexamethasone pegylated lipos... protein analysi... immunologic tec... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma | NCT01339663 | Recurrent Melan... Stage IV Melano... | cyclophosphamid... aldesleukin autologous tumo... laboratory biom... immunologic tec... immunohistochem... polymerase chai... therapeutic aut... | 18 Years - | Fred Hutchinson Cancer Center | |
| Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | NCT00453050 | Melanoma (Skin) Metastatic Canc... | imiquimod indocyanine gre... flow cytometry immunologic tec... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia | NCT00899743 | Leukemia | polyacrylamide ... western blottin... immunologic tec... laboratory biom... | 56 Years - | SWOG Cancer Research Network | |
| Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer | NCT01327794 | Pancreatic Canc... | polymorphism an... immunologic tec... laboratory biom... medical chart r... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes | NCT00454480 | Leukemia Myelodysplastic... | alemtuzumab arsenic trioxid... azacitidine busulfan clofarabine cytarabine daunorubicin hy... fludarabine pho... gemtuzumab ozog... melphalan tipifarnib DNA methylation... cytogenetic ana... gene expression... mutation analys... diagnostic labo... immunologic tec... allogeneic hema... nonmyeloablativ... | - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma | NCT00658892 | Melanoma (Skin) | B7-DC cross-lin... flow cytometry immunologic tec... laboratory biom... | 18 Years - 120 Years | Mayo Clinic | |
| DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia | NCT00899366 | Leukemia | microarray anal... mutation analys... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 | NCT00896701 | Leukemia | flow cytometry immunologic tec... laboratory biom... | 15 Years - | Alliance for Clinical Trials in Oncology | |
| DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia | NCT00897936 | Leukemia | DNA methylation... comparative gen... fluorescence in... microarray anal... polymerase chai... diagnostic labo... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia | NCT00899743 | Leukemia | polyacrylamide ... western blottin... immunologic tec... laboratory biom... | 56 Years - | SWOG Cancer Research Network | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer | NCT00899821 | Head and Neck C... | aldesleukin recombinant int... sargramostim immunologic tec... biopsy | 20 Years - 80 Years | NYU Langone Health | |
| Study of Proteins in Head and Neck Cancer Cells | NCT00896948 | Head and Neck C... | Southern blotti... TdT-mediated dU... gene expression... protein express... flow cytometry fluorescent ant... immunoenzyme te... immunohistochem... immunologic tec... | - 120 Years | Vanderbilt University Medical Center | |
| Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases | NCT00450983 | Graft Versus Ho... Leukemia Myelodysplastic... | muromonab-CD3 natural killer ... fludarabine pho... methotrexate thiotepa gene expression... flow cytometry immunologic tec... allogeneic hema... in vitro-treate... total-body irra... | - 45 Years | Fred Hutchinson Cancer Center | |
| Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors | NCT00878904 | Unspecified Adu... | epirubicin hydr... panobinostat gene expression... protein express... western blottin... immunologic tec... laboratory biom... pharmacological... | 18 Years - 120 Years | University of California, San Francisco | |
| Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer | NCT00897338 | Breast Cancer | flow cytometry fluorescence ac... immunohistochem... immunologic tec... biomarker analy... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00814164 | Leukemia | clofarabine daunorubicin hy... cytogenetic ana... protein express... immunologic tec... pharmacological... | 60 Years - 120 Years | Roswell Park Cancer Institute | |
| Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors | NCT00436761 | Unspecified Chi... | anti-thymocyte ... graft-versus-tu... sargramostim busulfan cyclosporine melphalan methylprednisol... flow cytometry immunologic tec... laboratory biom... allogeneic hema... umbilical cord ... | - 21 Years | National Cancer Institute (NCI) | |
| Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | NCT00673569 | Lung Cancer | erlotinib hydro... gene expression... protein express... immunoenzyme te... immunologic tec... laboratory biom... needle biopsy | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia | NCT01251159 | Leukemia | mutation analys... polymerase chai... immunologic tec... laboratory biom... | 16 Years - 60 Years | Eastern Cooperative Oncology Group | |
| Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy | NCT00466960 | Brenner Tumor Fallopian Tube ... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Mucinou... Ovarian Serous ... Ovarian Undiffe... Peritoneal Cavi... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | sargramostim paclitaxel albu... laboratory biom... immunologic tec... | 18 Years - | University of Washington | |
| Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer | NCT00897143 | Lung Cancer Metastatic Canc... | microarray anal... mutation analys... flow cytometry immunologic tec... | - | Case Comprehensive Cancer Center | |
| Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer | NCT00436254 | HER2-positive B... Stage III Ovari... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Stage IV Ovaria... | pNGVL3-hICD vac... sargramostim flow cytometry immunologic tec... immunoenzyme te... protein express... biopsy | 18 Years - | University of Washington | |
| Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer | NCT00436254 | HER2-positive B... Stage III Ovari... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Stage IV Ovaria... | pNGVL3-hICD vac... sargramostim flow cytometry immunologic tec... immunoenzyme te... protein express... biopsy | 18 Years - | University of Washington | |
| Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00814164 | Leukemia | clofarabine daunorubicin hy... cytogenetic ana... protein express... immunologic tec... pharmacological... | 60 Years - 120 Years | Roswell Park Cancer Institute | |
| Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma | NCT01339663 | Recurrent Melan... Stage IV Melano... | cyclophosphamid... aldesleukin autologous tumo... laboratory biom... immunologic tec... immunohistochem... polymerase chai... therapeutic aut... | 18 Years - | Fred Hutchinson Cancer Center | |
| Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer | NCT00892515 | Breast Cancer Healthy, no Evi... | exercise interv... counseling inte... gas chromatogra... immunoenzyme te... immunologic tec... laboratory biom... mass spectromet... physiologic tes... questionnaire a... survey administ... dual x-ray abso... magnetic resona... study of high r... | 18 Years - 35 Years | Abramson Cancer Center at Penn Medicine | |
| DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia | NCT00897936 | Leukemia | DNA methylation... comparative gen... fluorescence in... microarray anal... polymerase chai... diagnostic labo... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma | NCT00478075 | Multiple Myelom... | bortezomib immunologic tec... samarium Sm 153... | 18 Years - | Mayo Clinic | |
| Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer | NCT00897338 | Breast Cancer | flow cytometry fluorescence ac... immunohistochem... immunologic tec... biomarker analy... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17 | NCT00897065 | Breast Cancer | microarray anal... polymerase chai... protein express... diagnostic labo... fluorescent ant... immunohistochem... immunologic tec... | - | National Cancer Institute (NCI) | |
| Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants | NCT00900276 | Bladder Cancer Kidney Cancer Transitional Ce... Urethral Cancer | immunologic tec... laboratory biom... mass spectromet... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss | NCT00899158 | Cachexia Pancreatic Canc... | immunologic tec... laboratory biom... biopsy | 18 Years - | Case Comprehensive Cancer Center | |
| Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma | NCT00466687 | Melanoma | bevacizumab erlotinib hydro... fluorescence in... gene expression... immunologic tec... laboratory biom... biopsy | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma | NCT00755976 | Melanoma (Skin) | epirubicin hydr... sulindac immunologic tec... | 18 Years - | Cancer Trials Ireland | |
| Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer | NCT00892515 | Breast Cancer Healthy, no Evi... | exercise interv... counseling inte... gas chromatogra... immunoenzyme te... immunologic tec... laboratory biom... mass spectromet... physiologic tes... questionnaire a... survey administ... dual x-ray abso... magnetic resona... study of high r... | 18 Years - 35 Years | Abramson Cancer Center at Penn Medicine | |
| Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer | NCT00897338 | Breast Cancer | flow cytometry fluorescence ac... immunohistochem... immunologic tec... biomarker analy... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery | NCT00410956 | Liver Cancer | bevacizumab dexamethasone floxuridine protein express... flow cytometry immunoenzyme te... immunohistochem... immunologic tec... laboratory biom... dynamic contras... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer | NCT00897143 | Lung Cancer Metastatic Canc... | microarray anal... mutation analys... flow cytometry immunologic tec... | - | Case Comprehensive Cancer Center | |
| DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx | NCT00897988 | Head and Neck C... | gene expression... mutation analys... polyacrylamide ... polymerase chai... protein express... reverse transcr... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | - 120 Years | Vanderbilt University Medical Center | |
| Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma | NCT00466687 | Melanoma | bevacizumab erlotinib hydro... fluorescence in... gene expression... immunologic tec... laboratory biom... biopsy | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer | NCT00470574 | Breast Cancer | QS21 sialyl Lewisª-k... immunoenzyme te... immunologic tec... laboratory biom... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 | NCT00896662 | Lymphoma Solid Tumor | immunologic tec... laboratory biom... pharmacological... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial | NCT01424865 | Breast Cancer | fluorescence in... immunohistochem... immunologic tec... laboratory biom... | 18 Years - | NSABP Foundation Inc | |
| Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment | NCT00909831 | Unspecified Adu... | hydroxychloroqu... temsirolimus electron micros... high performanc... immunologic tec... laboratory biom... mass spectromet... pharmacological... autophagy inhib... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Cetuximab in Treating Patients With Advanced Solid Tumors | NCT00376727 | Unspecified Adu... | cetuximab molecular diagn... immunologic tec... laboratory biom... | 18 Years - | University of California, Davis | |
| DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia | NCT00899366 | Leukemia | microarray anal... mutation analys... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer | NCT00436709 | Breast Cancer | bevacizumab pegfilgrastim cyclophosphamid... doxorubicin hyd... paclitaxel albu... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... adjuvant therap... immunoscintigra... | 18 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma | NCT00658892 | Melanoma (Skin) | B7-DC cross-lin... flow cytometry immunologic tec... laboratory biom... | 18 Years - 120 Years | Mayo Clinic | |
| Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT00742404 | Multiple Myelom... | bortezomib dexamethasone pegylated lipos... protein analysi... immunologic tec... | 18 Years - | National Cancer Institute (NCI) | |
| Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors | NCT00436761 | Unspecified Chi... | anti-thymocyte ... graft-versus-tu... sargramostim busulfan cyclosporine melphalan methylprednisol... flow cytometry immunologic tec... laboratory biom... allogeneic hema... umbilical cord ... | - 21 Years | National Cancer Institute (NCI) | |
| Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer | NCT00899821 | Head and Neck C... | aldesleukin recombinant int... sargramostim immunologic tec... biopsy | 20 Years - 80 Years | NYU Langone Health |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
